SMALL INTESTINE CARCINOMA RECURRENT

This adverse event was reported 16 times

These drugs are most commonly taken by patients reporting SMALL INTESTINE CARCINOMA RECURRENT:

# Drug Count
0 EVEROLIMUS 2
1 TELOTRISTAT ETHYL 2
2 ADALIMUMAB 1
3 ADALIMUMAB-AATY 1
4 ADALIMUMAB-ADAZ 1
5 ADALIMUMAB-FKJP 1
6 ALENDRONATE SODIUM 1
7 AZATHIOPRINE 1
8 BEVACIZUMAB 1
9 CISPLATIN 1
See all common drugs associated with SMALL INTESTINE CARCINOMA RECURRENT

SMALL INTESTINE CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TELOTRISTAT ETHYL 2 0.0003
1 INFLIXIMAB-DYYB 1 0.0003
2 OLAPARIB 1 0.0000
3 EVEROLIMUS 2 0.0000
4 ERGOCALCIFEROL 1 0.0000
5 OLANZAPINE PAMOATE 1 0.0000
6 ADALIMUMAB-FKJP 1 0.0000
7 ADALIMUMAB-AATY 1 0.0000
8 GEMCITABINE HYDROCHLORIDE 1 0.0000
9 ADALIMUMAB-ADAZ 1 0.0000
See all drugs enriched for association with SMALL INTESTINE CARCINOMA RECURRENT